These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7972202)

  • 1. Prognostic value of MDR1 gene expression in neuroblastoma: results of a multivariate analysis.
    Bénard J; Bourhis J; de Vathaire F; Ferrandis E; Terrier-Lacombe MJ; Lemerle J; Riou G; Hartmann O
    Prog Clin Biol Res; 1994; 385():111-6. PubMed ID: 7972202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
    Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
    Ferrandis E; Da Silva J; Riou G; Bénard I
    Cancer Res; 1994 Apr; 54(8):2256-61. PubMed ID: 8174136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
    Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
    Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
    George RE; London WB; Cohn SL; Maris JM; Kretschmar C; Diller L; Brodeur GM; Castleberry RP; Look AT
    J Clin Oncol; 2005 Sep; 23(27):6466-73. PubMed ID: 16116152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
    Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
    Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
    Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overall genomic pattern is a predictor of outcome in neuroblastoma.
    Janoueix-Lerosey I; Schleiermacher G; Michels E; Mosseri V; Ribeiro A; Lequin D; Vermeulen J; Couturier J; Peuchmaur M; Valent A; Plantaz D; Rubie H; Valteau-Couanet D; Thomas C; Combaret V; Rousseau R; Eggert A; Michon J; Speleman F; Delattre O
    J Clin Oncol; 2009 Mar; 27(7):1026-33. PubMed ID: 19171713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology.
    Minard V; Hartmann O; Peyroulet MC; Michon J; Coze C; Defachelle AS; Lejars O; Perel Y; Bergeron C; Boutard P; Leverger G; Stephan JL; Thyss A; Chastagner P; Couillault G; Devalck C; Lutz P; Mechinaud F; Millot F; Plantaz D; Rialland X; Rubie H
    Br J Cancer; 2000 Oct; 83(8):973-9. PubMed ID: 10993641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients.
    Corrias MV; Cornaglia-Ferraris P; Di Martino D; Stenger AM; Lanino E; Boni L; Tonini GP
    Anticancer Res; 1990; 10(4):897-902. PubMed ID: 1974410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of N-myc gene amplification in bone marrow specimen of stage IV neuroblastoma patients.
    Brack T; Scholz RB; Milde-Langosch K; Heinsohn S; Löning T; Kabisch H
    Cancer Detect Prev; 1992; 16(3):185-92. PubMed ID: 1458508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
    Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)].
    Pession A; De Bernardi B; Perri P; Mazzocco K; Rondelli R; Nigro M; Iolascon A; Forni M; Basso G; Conte M
    Pediatr Med Chir; 1994; 16(3):211-8. PubMed ID: 7971442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma.
    Hiyama E; Hiyama K; Yokoyama T; Fukuba I; Yamaoka H; Shay JW; Matsuura Y
    Clin Cancer Res; 1999 Mar; 5(3):601-9. PubMed ID: 10100712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
    Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
    Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma.
    Mora J; Lavarino C; Alaminos M; Cheung NK; Ríos J; de Torres C; Illei P; Juan G; Gerald WL
    Genes Chromosomes Cancer; 2007 Apr; 46(4):385-96. PubMed ID: 17243159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
    Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
    Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.